956 related articles for article (PubMed ID: 25593480)
21. A randomized study of adefovir dipivoxil in place of HBIG in combination with lamivudine as post-liver transplantation hepatitis B prophylaxis.
Angus PW; Patterson SJ; Strasser SI; McCaughan GW; Gane E
Hepatology; 2008 Nov; 48(5):1460-6. PubMed ID: 18925641
[TBL] [Abstract][Full Text] [Related]
22. Limited hepatitis B immunoglobulin with potent nucleos(t)ide analogue is a cost-effective prophylaxis against hepatitis B virus after liver transplantation.
Singer GA; Zielsdorf S; Fleetwood VA; Alvey N; Cohen E; Eswaran S; Shah N; Chan EY; Hertl M; Fayek SA
Transplant Proc; 2015 Mar; 47(2):478-84. PubMed ID: 25769595
[TBL] [Abstract][Full Text] [Related]
23. Hepatitis B immunoglobulin and/or nucleos(t)ide analogues for prophylaxis against hepatitis b virus recurrence after liver transplantation: a systematic review.
Cholongitas E; Goulis J; Akriviadis E; Papatheodoridis GV
Liver Transpl; 2011 Oct; 17(10):1176-90. PubMed ID: 21656655
[TBL] [Abstract][Full Text] [Related]
24. HBV recurrence lowered by lamivudine/HBIG combination therapy in liver transplant patients: ten-year experience.
Yuan CH; Xiu DR; Jiang B; Li ZF; Li L; Song SB; Zhang TL
Hepatobiliary Pancreat Dis Int; 2013 Apr; 12(2):149-53. PubMed ID: 23558068
[TBL] [Abstract][Full Text] [Related]
25. Clinical-pathological analysis of hepatitis B virus recurrence after liver transplantation in Chinese patients.
Gao YJ; Zhang M; Jin B; Meng FP; Ma XM; Liu ZW; Su HB; Zhao JM; Li HW
J Gastroenterol Hepatol; 2014 Mar; 29(3):554-60. PubMed ID: 24117714
[TBL] [Abstract][Full Text] [Related]
26. The long-term efficacy of combining nucleos(t)ide analog and low-dose hepatitis B immunoglobulin on post-transplant hepatitis B virus recurrence.
Idilman R; Akyildiz M; Keskin O; Gungor G; Yilmaz TU; Kalkan C; Dayangac M; Cinar K; Balci D; Hazinedaroglu S; Tokat Y
Clin Transplant; 2016 Oct; 30(10):1216-1221. PubMed ID: 27409074
[TBL] [Abstract][Full Text] [Related]
27. Prophylactic use of low-dose, on-demand, intramuscular hepatitis B immunoglobulin and lamivudine after liver transplantation.
Karademir S; Astarcioğlu H; Akarsu M; Ozkardesler S; Ozzeybek D; Sayiner A; Akan M; Tankurt E; Astarcioğlu I
Transplant Proc; 2006 Mar; 38(2):579-83. PubMed ID: 16549180
[TBL] [Abstract][Full Text] [Related]
28. Low risk of hepatitis B virus recurrence after withdrawal of long-term hepatitis B immunoglobulin in patients receiving maintenance nucleos(t)ide analogue therapy.
Wong SN; Chu CJ; Wai CT; Howell T; Moore C; Fontana RJ; Lok AS
Liver Transpl; 2007 Mar; 13(3):374-81. PubMed ID: 17318855
[TBL] [Abstract][Full Text] [Related]
29. Antiviral treatment for hepatitis B virus recurrence following liver transplantation.
Lee S; Kwon CH; Moon HH; Kim TS; Roh Y; Song S; Shin M; Kim JM; Park JB; Kim SJ; Joh JW; Lee SK
Clin Transplant; 2013; 27(5):E597-604. PubMed ID: 24093615
[TBL] [Abstract][Full Text] [Related]
30. Nucleoside-Nucleotide Analog Combination Therapy Is Effective in Preventing Recurrent Hepatitis B After Liver Transplantation.
Khemichian S; Hsieh MJ; Zhang SR; Limurti J; Kim J; Fong TL
Dig Dis Sci; 2015 Sep; 60(9):2807-12. PubMed ID: 25939541
[TBL] [Abstract][Full Text] [Related]
31. Post-liver transplant hepatitis B prophylaxis: the role of oral nucleos(t)ide analogues.
Patterson SJ; Angus PW
Curr Opin Organ Transplant; 2009 Jun; 14(3):225-30. PubMed ID: 19373086
[TBL] [Abstract][Full Text] [Related]
32. Shorter hepatitis B immunoglobulin administration is not associated to hepatitis B virus recurrence when receiving combined prophylaxis after liver transplantation.
Lens S; García-Eliz M; Fernández I; Castells L; Bonacci M; Mas A; Crespo G; Buti M; Prieto M; Forns X
Liver Int; 2018 Nov; 38(11):1940-1950. PubMed ID: 29660249
[TBL] [Abstract][Full Text] [Related]
33. Living related liver transplantation for hepatitis B-related liver disease without hepatitis B immune globulin prophylaxis.
Wadhawan M; Gupta S; Goyal N; Taneja S; Kumar A
Liver Transpl; 2013 Sep; 19(9):1030-5. PubMed ID: 23788470
[TBL] [Abstract][Full Text] [Related]
34. An efficacy and cost-effectiveness analysis of combination hepatitis B immune globulin and lamivudine to prevent recurrent hepatitis B after orthotopic liver transplantation compared with hepatitis B immune globulin monotherapy.
Han SH; Ofman J; Holt C; King K; Kunder G; Chen P; Dawson S; Goldstein L; Yersiz H; Farmer DG; Ghobrial RM; Busuttil RW; Martin P
Liver Transpl; 2000 Nov; 6(6):741-8. PubMed ID: 11084061
[TBL] [Abstract][Full Text] [Related]
35. Antiviral Combination Therapy With Low-Dose Hepatitis B Immunoglobulin for the Prevention of Hepatitis B Virus Recurrence in Liver Transplant Recipients: A Single-Center Experience.
Akcam AT; Ulku A; Rencuzogullari A; Eray IC; Okoh A; Kuran S; Dalcı K; Yalav O; Parsak CK; Sakman G; Demiryurek H
Transplant Proc; 2015 Jun; 47(5):1445-9. PubMed ID: 26093739
[TBL] [Abstract][Full Text] [Related]
36. Intramuscular hepatitis B immunoglobulin (HBIG) and nucleosides for prevention of recurrent hepatitis B following liver transplantation: comparison with other HBIG regimens.
Anderson RD; Chinnakotla S; Guo L; Perrillo RP; Klintmalm GB; Davis GL
Clin Transplant; 2007; 21(4):510-7. PubMed ID: 17645711
[TBL] [Abstract][Full Text] [Related]
37. Adefovir dipivoxil therapy in liver transplant recipients for recurrence of hepatitis B virus infection despite lamivudine plus hepatitis B immunoglobulin prophylaxis.
Akyildiz M; Karasu Z; Zeytunlu M; Aydin U; Ozacar T; Kilic M
J Gastroenterol Hepatol; 2007 Dec; 22(12):2130-4. PubMed ID: 18031370
[TBL] [Abstract][Full Text] [Related]
38. Does pre-liver transplant HBV DNA level affect HBV recurrence or survival in liver transplant recipients receiving HBIg and nucleos(t)ide analogues?
Campos-Varela I; Castells L; Buti M; Vargas V; Bilbao I; Rodríguez-Frías F; Jardí R; Charco R; Guardia J; Esteban R
Ann Hepatol; 2011; 10(2):180-7. PubMed ID: 21502680
[TBL] [Abstract][Full Text] [Related]
39. Reevaluation of the effect of lamivudine therapy preoperative to prevent HBV recurrence after liver transplantation.
Lu AW; Zheng SS; Wu MP; Shen Y; Yang RW
Hepatobiliary Pancreat Dis Int; 2008 Aug; 7(4):357-61. PubMed ID: 18693169
[TBL] [Abstract][Full Text] [Related]
40. Prevention and risk factors of the HBV recurrence after orthotopic liver transplantation: 160 cases follow-up study.
Xie SB; Zhu JY; Ying Z; Zeng LJ; Chao M; Lu MQ
Transplantation; 2010 Oct; 90(7):786-90. PubMed ID: 20703179
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
